124 related articles for article (PubMed ID: 27139467)
21. Antitrypanosomal activity of phosphonylmethoxyalkylpurines.
Kaminsky R; Zweygarth E; De Clercq E
J Parasitol; 1994 Dec; 80(6):1026-30. PubMed ID: 7799144
[TBL] [Abstract][Full Text] [Related]
22. Discovery of potent nitrotriazole-based antitrypanosomal agents: In vitro and in vivo evaluation.
Papadopoulou MV; Bloomer WD; Rosenzweig HS; O'Shea IP; Wilkinson SR; Kaiser M; Chatelain E; Ioset JR
Bioorg Med Chem; 2015 Oct; 23(19):6467-76. PubMed ID: 26344593
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro antitrypanosomal evaluation of novel 6-heteroarylidene-substituted quinolone derivatives.
Angula KT; Legoabe LJ; Swart T; Hoppe HC; Beteck RM
Eur J Med Chem; 2022 Jan; 227():113913. PubMed ID: 34656043
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin.
Ishiyama A; Otoguro K; Iwatsuki M; Namatame M; Nishihara A; Nonaka K; Kinoshita Y; Takahashi Y; Masuma R; Shiomi K; Yamada H; Omura S
J Antibiot (Tokyo); 2009 Jun; 62(6):303-8. PubMed ID: 19407848
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo antitrypanosomal activitiy of two microbial metabolites, KS-505a and alazopeptin.
Ishiyama A; Otoguro K; Namatame M; Nishihara A; Furusawa T; Masuma R; Shiomi K; Takahashi Y; Ichimura M; Yamada H; Omura S
J Antibiot (Tokyo); 2008 Oct; 61(10):627-32. PubMed ID: 19168977
[TBL] [Abstract][Full Text] [Related]
26. Effect of ivermectin on Trypanosoma brucei brucei in experimentally infected mice.
Udensi UK; Fagbenro-Beyioku AF
J Vector Borne Dis; 2012 Sep; 49(3):143-50. PubMed ID: 23135008
[TBL] [Abstract][Full Text] [Related]
27. Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy.
Zheng Y; van den Kerkhof M; van der Meer T; Gul S; Kuzikov M; Ellinger B; de Esch IJP; Siderius M; Matheeussen A; Maes L; Sterk GJ; Caljon G; Leurs R
J Med Chem; 2023 Aug; 66(15):10252-10264. PubMed ID: 37471520
[TBL] [Abstract][Full Text] [Related]
28. Trypanocidal activity of methylene blue. Evidence for in vitro efficacy and in vivo failure.
Boda C; Enanga B; Courtioux B; Breton JC; Bouteille B
Chemotherapy; 2006; 52(1):16-9. PubMed ID: 16340192
[TBL] [Abstract][Full Text] [Related]
29. Novel triazine dimers with potent antitrypanosomal activity.
Venkatraj M; Salado IG; Heeres J; Joossens J; Lewi PJ; Caljon G; Maes L; Van der Veken P; Augustyns K
Eur J Med Chem; 2018 Jan; 143():306-319. PubMed ID: 29197735
[TBL] [Abstract][Full Text] [Related]
30. DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity.
Dardonville C; Barrett MP; Brun R; Kaiser M; Tanious F; Wilson WD
J Med Chem; 2006 Jun; 49(12):3748-52. PubMed ID: 16759117
[TBL] [Abstract][Full Text] [Related]
31. Novel 3-nitrotriazole-based amides and carbinols as bifunctional antichagasic agents.
Papadopoulou MV; Bloomer WD; Lepesheva GI; Rosenzweig HS; Kaiser M; Aguilera-Venegas B; Wilkinson SR; Chatelain E; Ioset JR
J Med Chem; 2015 Feb; 58(3):1307-19. PubMed ID: 25580906
[TBL] [Abstract][Full Text] [Related]
32. Screening North American plant extracts in vitro against Trypanosoma brucei for discovery of new antitrypanosomal drug leads.
Jain S; Jacob M; Walker L; Tekwani B
BMC Complement Altern Med; 2016 May; 16():131. PubMed ID: 27193901
[TBL] [Abstract][Full Text] [Related]
33. Pyridyl benzamides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei.
Ferrins L; Gazdik M; Rahmani R; Varghese S; Sykes ML; Jones AJ; Avery VM; White KL; Ryan E; Charman SA; Kaiser M; Bergström CA; Baell JB
J Med Chem; 2014 Aug; 57(15):6393-402. PubMed ID: 24978605
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a melamino nitroheterocycle as a potential lead for the treatment of human african trypanosomiasis.
Giordani F; Buschini A; Baliani A; Kaiser M; Brun R; Barrett MP; Pellacani C; Poli P; Gilbert IH
Antimicrob Agents Chemother; 2014 Oct; 58(10):5747-57. PubMed ID: 25022590
[TBL] [Abstract][Full Text] [Related]
35. Trypanosoma brucei brucei: antitrypanosomal evaluation of stilbamidinium hexachloroiridiate on the murine CNS model and iridium serum kinetics in infected sheep.
Dreyfuss G; Loiseau PM; Lachâtre G; Pénicaut B; Nicolas JA; Craciunescu DG
Trop Med Parasitol; 1995 Mar; 46(1):41-4. PubMed ID: 7631127
[TBL] [Abstract][Full Text] [Related]
36. Eflornithine for the treatment of human African trypanosomiasis.
Burri C; Brun R
Parasitol Res; 2003 Jun; 90 Supp 1():S49-52. PubMed ID: 12811548
[TBL] [Abstract][Full Text] [Related]
37. Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei.
Zimmermann S; Kaiser M; Brun R; Hamburger M; Adams M
Planta Med; 2012 Apr; 78(6):553-6. PubMed ID: 22331812
[TBL] [Abstract][Full Text] [Related]
38. Diphenyl furans and aza analogs: effects of structural modification on in vitro activity, DNA binding, and accumulation and distribution in trypanosomes.
Mathis AM; Bridges AS; Ismail MA; Kumar A; Francesconi I; Anbazhagan M; Hu Q; Tanious FA; Wenzler T; Saulter J; Wilson WD; Brun R; Boykin DW; Tidwell RR; Hall JE
Antimicrob Agents Chemother; 2007 Aug; 51(8):2801-10. PubMed ID: 17517831
[TBL] [Abstract][Full Text] [Related]
39. Diamidines for human African trypanosomiasis.
Paine MF; Wang MZ; Generaux CN; Boykin DW; Wilson WD; De Koning HP; Olson CA; Pohlig G; Burri C; Brun R; Murilla GA; Thuita JK; Barrett MP; Tidwell RR
Curr Opin Investig Drugs; 2010 Aug; 11(8):876-83. PubMed ID: 20721830
[TBL] [Abstract][Full Text] [Related]
40. In vitro trypanocidal activity of dibutyltin dichloride and its fatty acid derivatives.
Shuaibu MN; Kanbara H; Yanagi T; Ichinose A; Ameh DA; Bonire JJ; Nok AJ
Parasitol Res; 2003 Sep; 91(1):5-11. PubMed ID: 12851812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
